Viraj Master Profile
Viraj Master

@virajmaster

Followers
1K
Following
2K
Media
38
Statuses
697

-Cancer Surgeon, Mines host-tumor interaction, and operates on tumors involving the vena cava -Director of Integrative Oncology and Survivorship, Winship

Emory University
Joined May 2013
Don't wanna be here? Send us removal request.
@BrentToderian
Brent Toderian
3 years
Remember this picture every single time you hear someone in your city say "we're not Amsterdam." This was #Amsterdam in the 1970's via @fietsprofessor. The cities we admire made better choices regarding cars, and are still making them today. Better choices instead of excuses.
76
2K
7K
@virajmaster
Viraj Master
4 years
Upfront setup work is little more, but the time savings with unparalleled exposure more than makes up for it.
@drphil_urology
Phillip Pierorazio
4 years
1
0
9
@virajmaster
Viraj Master
4 years
Always nice when the data supports a hypothesis. Lots of work to do to reverse the frailty phenotype. Low free testosterone is associated with increased mortality in frail ...
0
4
8
@virajmaster
Viraj Master
4 years
The discrimination between vital versus urgent, is a learn-able skill. I continue to learn this skill.
@NakadaSteve
Steve Nakada
4 years
Most of us spend too much time on what is urgent, and not enough time on what is important. S Covey. Use the holidays to catch up and recharge! #MondayMotivation #leadership @wiscurology
0
0
6
@virajmaster
Viraj Master
4 years
Thank goodness smart physicians like you and other friends are trying to figure this one out, fingers crossed 🤞 that Reviewer 1 is not a hater!
0
0
2
@virajmaster
Viraj Master
4 years
.@rezanab did a super job investigating the use of complementary medicine to affect bladder cancer treatment symptoms, which really afflict patients. Soy (Geninstein) is effective, and cost effective @Integrativeonc
@VikramNarayan
Vikram M. Narayan, MD
4 years
Very nice work presented by one of our @emory_urology chief residents (and future @MayoUrology @UroOnc fellow!) @rezanab investigating the role of antioxidant supplementation to potentiate BCG efficacy & tolerability for NMIBC treatment @virajmaster @ssjoshimd #SUO2021 @SUO_YUO
0
4
18
@virajmaster
Viraj Master
4 years
Dr. Curtis Pettaway from @MDAndersonNews receiving the #SUO2021 Huggins Medal. Supremely well deserved.
1
2
44
@virajmaster
Viraj Master
4 years
And I would add, these are *remarkably* cost-effective markers. By which, I mean, 10-20 USD. These biomarkers are *both* prognostic, and the holy grail, predictive. Super congrats to my good friend @bilenma and my brother @DrDonaldHarvey to lead these @WinshipAtEmory efforts.
@JournalCancer
ACS Journal Cancer
4 years
This top-cited paper co-authored by our EIC @RamalingamMD investigated the assoc b/w inflammatory markers and clinical outcomes of patients w/ adv-stage cancer who received #immunotherapy: https://t.co/62yXkpi6eF #SITC21 @virajmaster @teekayowo
0
4
15
@virajmaster
Viraj Master
4 years
Just voted in Georgia elections, polls open til 7, vote!
0
0
24
@virajmaster
Viraj Master
4 years
Wonderful news, and so well deserved. Patients will benefit from Dr. Bergerot's work.
@crisbergerot
Cristiane D Bergerot, PhD, FASCO
4 years
🔔Humbled, honored, & extremely grateful to be awarded the 1st @KidneyCancer Focus Award: Psychosocial I’m so thrilled to be conducting this research w my mentor @tompowles1 in a project w @erplimack @drchoueiri @virajmaster @montypal @spsutkaMD @brianrini @AlbigesL et al 🎉
1
4
16
@jdimick1
Justin B. Dimick
4 years
We all have those favorite papers that we feel like aren’t read enough—this one with @spshubeck is one of mine! The surgeons with the best outcomes are humble and open to feedback—they are programmed to improve. What’s yours?
@BrianTillMD
Brian M. Till
4 years
.@jdimick1: "Do you think surgical skill is a cognitive or physical skill? I think it's cognitive. My favorite paper that nobody reads is where we correlated outcomes to personality. Aggressive, not open to feedback personalities have the worst outcomes." https://t.co/4XRy9xwgDZ
2
35
150
@rezanab
Reza Nabavizadeh, MD
4 years
Thank you 🙏 for involving us to contribute a chapter on Management of Non-Palpable/Non-Bulky Inguinal Nodes. It was a great opportunity. I learned so much from everyone, mainly 👉🥇 @virajmaster 🥇👈
@AndreaNecchi
Andrea Necchi
4 years
Very happy to be co-editor of this reference Textbook on #penilecancer with @SpiessPhilippe Pursuing research on #rarecancers @GTumors @SpringerNature
1
1
4
@virajmaster
Viraj Master
4 years
Thanks to ⁦@tingbao2011⁩ for 2 years of dedicated service as ⁦@Integrativeonc⁩ SIO President, tremendous leadership, particularly during the pandemic! Looking forward to the next 2 years ⁦@Linda_E_Carlson⁩ !
0
5
18
@virajmaster
Viraj Master
4 years
Dr Channing Paller, co-Chair of the ⁦@Integrativeonc#Sio2021, kicks off the opening session. I’ve already learned so much at the preconference workshops. My oncology colleagues, consider attending next year!
0
6
15
@virajmaster
Viraj Master
4 years
Super congratulations, Steve.
@MayoUrology
Mayo Clinic Urology
4 years
Congratulations to @SBoorjian on his new role as Department Chair for Urology at @MayoClinic. Dr. Boorjian is a recipient of the Carl Rosen professorship, the Vice Chair for Research, & director of our #UroOnc Fellowship. We look forward to his leadership.
0
0
0
@virajmaster
Viraj Master
4 years
Wonderful congratulations! So very well deserved, Professor Boorjian, who leads with great ability and humility.
@kvnkoo
Kevin Koo
4 years
Congratulations to Dr. Stephen A. Boorjian @SBoorjian, today appointed Chair of the Department of Urology at Mayo Clinic. Dr. Boorjian is the Carl Rosen Professor in Urology, vice chair of research, and @UroOnc fellowship director. Thanks @BradLeibovichMD for 8 yrs of leadership!
0
1
22
@virajmaster
Viraj Master
4 years
To optimize early recovery of the surgical patient, don't forget there are many complementary non-pharmacolgic approaches, including PC6 acutherapy for post op N/V. Thanks to Dr. Maggie Diller for teaching us about valuable tools in this review. https://t.co/vOJXMiOo2P
0
6
14